Vor Biopharma (VOR)
NASDAQ:VOR
US Market
Holding VOR?
Track your performance easily

Vor Biopharma (VOR) Financial Statements

500 Followers

Vor Biopharma Financial Overview

Vor Biopharma's market cap is currently ―. The company's EPS TTM is $-1.777; its P/E ratio is -0.53; Vor Biopharma is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -28.12M$ -35.32M$ -29.98M$ -30.42M$ -24.73M
EBITDA$ -27.23M$ -35.32M$ -28.01M$ -30.82M$ -24.13M
Net Income Common Stockholders$ -26.26M$ -33.19M$ -29.98M$ -28.43M$ -23.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 137.18M$ 160.10M$ 186.90M$ 210.20M$ 230.25M
Total Assets$ 198.13M$ 223.02M$ 250.99M$ 277.53M$ 299.37M
Total Debt$ 35.66M$ 36.60M$ 37.51M$ 38.45M$ 38.91M
Net Debt$ -101.52M$ -123.50M$ -149.39M$ -171.75M$ -191.33M
Total Liabilities$ 47.40M$ 48.24M$ 46.54M$ 47.32M$ 48.76M
Stockholders Equity$ 150.72M$ 174.78M$ 204.45M$ 230.22M$ 250.61M
Cash Flow-
Free Cash Flow$ -24.14M$ -28.36M$ -24.47M$ -24.40M$ -18.67M
Operating Cash Flow$ -24.03M$ -27.90M$ -24.07M$ -24.30M$ -18.35M
Investing Cash Flow$ 10.34M$ 40.54M$ 13.64M$ 6.50M$ -97.04M
Financing Cash Flow$ 25.00K$ 176.00K$ 218.00K$ 2.52M$ 112.26M
Currency in USD

Vor Biopharma Earnings and Revenue History

Vor Biopharma Debt to Assets

Vor Biopharma Cash Flow

Vor Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis